
Dhrumentis Pharmaceuticals Private Limited
About Dhrumentis Pharmaceuticals Private Limited
Data last updated:
Dhrumentis Pharmaceuticals Private Limited is a private limited company based in Khalilabad, Uttar Pradesh, India. It was incorporated on 24 July 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U46497UP2023PTC186104.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shashi Gupta and Rituraj Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khalilabad, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹72,723 (net margin 1.1%) and EBITDA of ₹98,276 (EBITDA margin 1.4%).
Company details
Contact details
Dhrumentis Pharmaceuticals Private Limited's registered office is in Khalilabad, Uttar Pradesh.
- Registered Address207 Moti Nagar, Near Gokul Sweet House Mehndawal Road, Khalilabad, Uttar Pradesh, India – 272173
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dhrumentis Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Dhrumentis Pharmaceuticals Private Limited, buy the company report.
Financials of Dhrumentis Pharmaceuticals Private Limited
FY 2025 filings availableDhrumentis Pharmaceuticals Private Limited reported revenue of ₹68.07 Lakh (up 685% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 685% in the latest year. EBITDA rose 642% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹98,276 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹72,723 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.4% | |
| Net Profit Margin | 1.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Dhrumentis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dhrumentis Pharmaceuticals Private Limited
Dhrumentis Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shashi Gupta | Director | 24 Jul 2023 | 3 Years 3 Months | Current |
| Rituraj Kumar Gupta Also directs: Ramvey Healthcare Private Limited | Director | 24 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Dhrumentis Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amnour Pharmaceuticals Private Limited | ₹68.69 Lakh (FY 2025) | 50.0% | Pune, Maharashtra, India | |||
| Stella Pharmaceuticals Private Limited | ₹68.56 Lakh (FY 2025) | 131.0% | Nagpur, Maharashtra, India | |||
| Dhrumentis Pharmaceuticals Private Limitedthis company | ₹68.07 Lakh (FY 2025) | ₹72,723 | 1.1% | 685.0% | Khalilabad, Uttar Pradesh, India | |
| Omarion Pharmaceuticals Private Limited | ₹68.06 Lakh (FY 2025) | Dadri, Uttar Pradesh, India |
To see the full peer comparison of Dhrumentis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dhrumentis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dhrumentis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dhrumentis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dhrumentis Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Rituraj Kumar Gupta was appointed as Director on 24 Jul 2023.
Frequently asked questions
Dhrumentis Pharmaceuticals is an active private limited company based in Khalilabad, Uttar Pradesh, India. It was incorporated on 24 July 2023 (3+ years old) and is registered under CIN U46497UP2023PTC186104.
Dhrumentis Pharmaceuticals has 2 current directors:
- Shashi Gupta - Director
- Rituraj Kumar Gupta - Director
The latest financial statements of Dhrumentis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Dhrumentis Pharmaceuticals is U46497UP2023PTC186104. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dhrumentis Pharmaceuticals was incorporated on 24 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Dhrumentis Pharmaceuticals by revenue are Amnour Pharmaceuticals Private Limited, Stella Pharmaceuticals Private Limited, Omarion Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Rituraj Kumar Gupta was appointed as Director on 24 Jul 2023. Shashi Gupta was appointed as Director on 24 Jul 2023.
The registered office of Dhrumentis Pharmaceuticals is at 207 Moti Nagar, Near Gokul Sweet House Mehndawal Road, Khalilabad, Uttar Pradesh, India – 272173.
Dhrumentis Pharmaceuticals can be reached at its registered office: 207 Moti Nagar, Near Gokul Sweet House Mehndawal Road, Khalilabad, Uttar Pradesh, India – 272173.
Dhrumentis Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.

